Evidence map›Paper›PMID 35354845›Full record

ArticleScientific reports2022

Mutations of the DNA repair gene PNKP in a patient with microcephaly, seizures, and developmental delay (MCSZ) presenting with a high-grade brain tumor.

Bingcheng Jiang, Cameron Murray, Bonnie L Cole, J N Mark Glover, Gordon K Chan, Jean Deschenes, Rajam S Mani, Sudip Subedi, John D Nerva, Anthony C Wang and 6 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Compound HeterozygousNeuroSci · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Bingcheng JiangDepartment of Oncology, University of Alberta, Cross Cancer Institute, 11560 University Ave., Edmonton, AB, T6G 1Z2, Canada.
Cameron MurrayDepartment of Biochemistry, University of Alberta, Medical Sciences Building, Edmonton, AB, T6G 2H7, Canada.
Bonnie L ColeDepartment of Pathology, University of Washington, Seattle, WA, USA.
J N Mark GloverDepartment of Biochemistry, University of Alberta, Medical Sciences Building, Edmonton, AB, T6G 2H7, Canada.
Gordon K ChanDepartment of Oncology, University of Alberta, Cross Cancer Institute, 11560 University Ave., Edmonton, AB, T6G 1Z2, Canada.
Jean DeschenesDepartment of Laboratory Medicine and Pathology, University of Alberta, Cross Cancer Institute, 11560 University Ave., Edmonton, AB, T6G 1Z2, Canada.
Rajam S ManiDepartment of Oncology, University of Alberta, Cross Cancer Institute, 11560 University Ave., Edmonton, AB, T6G 1Z2, Canada.
Sudip SubediDepartment of Oncology, University of Alberta, Cross Cancer Institute, 11560 University Ave., Edmonton, AB, T6G 1Z2, Canada.
John D NervaDepartment of Neurological Surgery, Tulane University, New Orleans, LA, USA.
Anthony C WangDepartment of Neurological Surgery, University of California Los Angeles, Los Angeles, CA, USA.
Christina M LockwoodDepartment of Laboratory Medicine, University of Washington, Seattle, WA, USA.
Heather C MeffordDivision of Genetics Medicine, University of Washington, Seattle, WA, USA.
Sarah E S LearyDivision of Pediatric Hematology/Oncology, Seattle Children's Hospital, Seattle, WA, USA.
Jeffery G OjemannDepartment of Neurological Surgery, University of Washington, Seattle, WA, USA.
Michael WeinfeldDepartment of Oncology, University of Alberta, Cross Cancer Institute, 11560 University Ave., Edmonton, AB, T6G 1Z2, Canada. mweinfel@ualberta.ca.
Chibawanye I EneDepartment of Neurological Surgery, MD Anderson Cancer Center, Houston, TX, USA. cene@mdanderson.org.
University of Alberta · CAUniversity of Washington · USNeurological Surgery · USSeattle Children's Hospital · USThe University of Texas MD Anderson Cancer Center · USTulane University · US

Funding

UCLA SPORE in Brain CancerP50CA211015 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Yvonne Yu-Hsuan Chen · 2017 to 2026
$25.2M
Neurosurgery research training in interdisciplinary neuroscienceR25NS079200 · NINDS · UNIVERSITY OF WASHINGTON · PI OJEMANN, JEFFREY G · 2012 to 2021
$1.2M
NCI NIH HHS P50 CA211015NINDS NIH HHS R25 NS079200NINDS NIH HHS R25NS079200
6 · The paper itself

Abstract

Polynucleotide Kinase-Phosphatase (PNKP) is a bifunctional enzyme that possesses both DNA 3'-phosphatase and DNA 5'-kinase activities, which are required for processing termini of single- and double-strand breaks generated by reactive oxygen species (ROS), ionizing radiation and topoisomerase I poisons. Even though PNKP is central to DNA repair, there have been no reports linking PNKP mutations in a Microcephaly, Seizures, and Developmental Delay (MSCZ) patient to cancer. Here, we characterized the biochemical significance of 2 germ-line point mutations in the PNKP gene of a 3-year old male with MSCZ who presented with a high-grade brain tumor (glioblastoma multiforme) within the cerebellum. Functional and biochemical studies demonstrated these PNKP mutations significantly diminished DNA kinase/phosphatase activities, altered its cellular distribution, caused defective repair of DNA single/double stranded breaks, and were associated with a higher propensity for oncogenic transformation. Our findings indicate that specific PNKP mutations may contribute to tumor initiation within susceptible cells in the CNS by limiting DNA damage repair and increasing rates of spontaneous mutations resulting in pediatric glioma associated driver mutations such as ATRX and TP53.

Indexed as

Brain NeoplasmsMicrocephalyChildChild, PreschoolDNA RepairDNA Repair EnzymesHumansMaleMutationPhosphotransferases (Alcohol Group Acceptor)SeizuresDNA Repair EnzymesPhosphotransferases (Alcohol Group Acceptor)PNKP protein, human

Identifiers

PMID35354845
PMCPMC8967877
OpenAlexW4221031664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.